[{"symbol": "MEDP", "price": 610.9, "beta": 1.435, "volAvg": 269495, "mktCap": 17207967431, "lastDiv": 0, "range": "250.05-628.916", "changes": -7.14, "companyName": "Medpace Holdings, Inc.", "currency": "USD", "cik": "0001668397", "isin": "US58506Q1094", "cusip": "58506Q109", "exchange": "NASDAQ Global Select", "exchangeShortName": "NASDAQ", "industry": "Medical - Diagnostics & Research", "website": "https://www.medpace.com", "description": "Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.", "ceo": "August James Troendle", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "5900", "phone": "513 579 9911", "address": "5375 Medpace Way", "city": "Cincinnati", "state": "OH", "zip": "45227", "dcfDiff": 98.15246, "dcf": 512.747536823695, "image": "https://images.financialmodelingprep.com/symbol/MEDP.png", "ipoDate": "2016-08-11", "defaultImage": false, "isEtf": false, "isActivelyTrading": true, "isAdr": false, "isFund": false}]